Double-deleted Vaccinia Virus Plus CD/ SMR

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDouble-deleted Vaccinia Virus Plus CD/ SMR
Drug Alias NamevvDD-CDSRJX-929
ClassificationBiologics
Mechanisms of ActionSomatostatin receptor modulatorsEpidermal growth factor receptor erbB1 modulatorsCytosine deaminase modulators
TargetsCytosine deaminaseSomatostatin receptorEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsColorectal Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSillajen Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of PittsburghSillajen Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsLiver NeoplasmsColorectal Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A